| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in OpenEMR 5.0.2.1. This affects an unknown function. Executing a manipulation of the argument Profile can lead to cross site scripting. This vulnerability is handled as CVE-2021-47817. The attack can be executed remotely. Additionally, an exploit exists.
Details
A vulnerability was found in OpenEMR 5.0.2.1. It has been declared as problematic. This vulnerability affects an unknown functionality. The manipulation of the argument profile with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
OpenEMR 5.0.2.1 contains a cross-site scripting vulnerability in user profile parameters that authenticated attackers can chain with a file upload to achieve remote code execution. Attackers can exploit the vulnerability by crafting a malicious payload to download and execute a web shell, enabling remote command execution on the vulnerable OpenEMR instance.
The weakness was released by Hato0 and Bvthtrd as 49784. The advisory is shared for download at exploit-db.com. This vulnerability was named CVE-2021-47817 since 01/14/2026. The exploitation appears to be easy. The attack can be initiated remotely. Successful exploitation requires user interaction by the victim. Technical details and also a public exploit are known. The MITRE ATT&CK project declares the attack technique as T1059.007.
It is possible to download the exploit at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at Exploit-DB (49784). Once again VulDB remains the best source for vulnerability data.
Product
Type
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.3
VulDB Base Score: 3.5
VulDB Temp Score: 3.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 5.4
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Access: Public
Status: Proof-of-Concept
Download: 🔒
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔒
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
01/14/2026 CVE reserved01/21/2026 Advisory disclosed
01/21/2026 VulDB entry created
05/27/2026 VulDB entry last update
Sources
Advisory: 49784Researcher: Hato0, Bvthtrd
Status: Not defined
CVE: CVE-2021-47817 (🔒)
GCVE (CVE): GCVE-0-2021-47817
GCVE (VulDB): GCVE-100-342196
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 01/21/2026 20:09Updated: 05/27/2026 02:06
Changes: 01/21/2026 20:09 (80), 05/26/2026 03:03 (1), 05/27/2026 02:06 (1)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.